Molecular, clinical, and therapeutic determinants of outcome in <i>NPM1</i>-mutated AML
Most Cited Paper
in Acute Myeloid Leukemia Research
18 Months Post-Publication
Class of 2026
“Molecular, clinical, and therapeutic determinants of outcome in <i>NPM1</i>-mutated AML”
A research intelligence initiative by Pepkio
pri.pepkio.com
Topics
NPM1-mutated AML · FLT3-internal tandem duplication · Measurable residual disease (MRD) · DNMT3A · WT1 mutation · non-ABD NPM1 mutation · Adverse-risk cytogenetics · cumulative incidence of relapse · Overall survival · Allogeneic hematopoietic stem cell transplantation (allo-HSCT) · FLAG-Ida regimen · fludarabine · cytarabine · idarubicin · postinduction MRD status · Risk stratification · Intensive chemotherapy · molecular subgroups · First complete remission
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Acute Myeloid Leukemia Research Papers, Class of 2026. https://pri.pepkio.com/top-papers/acute-myeloid-leukemia-research/2026. Accessed 2026-07-31. Methodology Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459